In various solid tumors, such as ovarian (73, 74), colorectal (75, 76), and pancreatic cancers (77, 78), aberrant activation of the MyD88 pathway in tumor-infiltrating myeloid cells leads to excessive production of immunosuppressive cytokines like IL-10 and TGF-β. This evidence concerns the gene MYD88 and neoplasm.